{"id": "1380077009494216704", "creation": 1617870974.0, "user_id": "20041712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 5, "reply_count": 1, "like_count": 11, "quote_count": 1}}, "text": "$OCGN ideally following PRs to come\n1. @Ocugen getting Marketing/distribution rights for whole North America\n2. Phase 3.2 Data with 90% efficacy \n3. Ocugen partnering with @GSK to produce #COVAXIN in #US \n4. Filling EUA with @US_FDA l\n5. Approval \n@BharatBiotech #COVID19 #vaccine", "first_save": 1634559108.199414, "hashtags": ["#COVAXIN", "#US", "#COVID19", "#VACCINE"]}